Weekend capacity for the skin cancer pathway you already run.
DermBiopsy Solutions delivers consultant-led biopsy and minor operations lists inside your Trust’s own facilities — adding throughput to urgent suspected skin cancer pathways without disturbing weekday services.
Surgical procedures · diagnostic and screening · treatment of disease, disorder or injury.
GMC-registered surgeons on the specialist register for their specialty.
Your theatres, your pathways, your pathology and records.
Held alongside agreed SOPs, consent and escalation routes.
Backlog trajectory · illustrative
Cases delivered in one weekend
DNA rate on insourced lists
Procedures per structured weekend
Discharge model
Being seen quickly is not the same as being diagnosed quickly.
A Trust can hold the 14-day appointment standard and still breach at 28 days, because the biopsy list sits weeks behind the clinic. Procedural capacity is where most of the window is lost — and it is the part insourcing can actually move.
The second half is the exposure. Clinic capacity protects the first fourteen days. Theatre capacity protects the rest — and it is the half that is hardest to flex inside a fully committed weekday timetable.
Four pressures, one constraint.
Rising dermatology demand, backlog pressure, workforce shortages and pathway targets all converge on available procedural time.
Rising demand
Consistent year-on-year increase in urgent suspected skin cancer referrals, with no matching increase in theatre time.
Growing backlogs
Difficulty meeting the 14-day standard for initial assessment, and the diagnostic window that follows it.
Workforce constraints
National shortages of specialist clinicians and surgical workforce capacity.
Limited weekday capacity
Theatre and clinic time is fully committed. Backlog cannot be absorbed without displacing other activity.
Pathway breaches carry a clinical cost, not just a reported one.
Delay increases the risk of later-stage diagnosis and extends the period of patient anxiety between referral and answer. Recovering the pathway is a clinical objective before it is a performance one.
A turnkey insourcing model.
We integrate with your Trust to provide weekend and evening biopsy lists, clearing backlogs without disrupting your core weekday services.
Led by UK consultant surgeons
Specialist experience in skin cancer surgery, biopsy pathways and reconstruction. Every list is run at consultant level, with experienced surgical nursing staff alongside. Seniority is not flexed to increase throughput.
Nothing leaves the Trust
Patients are selected via Trust pathways, procedures are performed on site, specimens go through existing pathology services, and documentation stays inside Trust systems. Follow-up is managed via your existing pathways and local clinical ownership.
Benefits to Trusts.
Flexible delivery
- Rapid reduction of 2WW skin cancer backlog pressures
- Optimised use of weekend estate
- No impact on weekday service delivery
- Fully consultant-led care model
- Predictable, scalable capacity
- Short-term 2WW skin cancer backlog reduction initiatives
- Ongoing weekend procedural capacity provision
- Targeted 2WW skin cancer pathway support
What runs on the list.
Excisional biopsies
With reconstruction as required, including local flaps and grafts.
Incisional biopsies
Where partial sampling is clinically indicated.
Punch biopsies
Standard diagnostic sampling under local anaesthetic.
Curettage and cautery
Delivered within structured minor operations lists.
Weekend and evening lists
Scheduled around your existing weekday activity.
Cryotherapy
For appropriate lesion types within the agreed case mix.
From capacity gap to completed pathway.
Identify need
Trust identifies a backlog or capacity gap within the skin cancer pathway.
Agree pathway
We agree case mix, list structure, staffing and governance arrangements with the Trust.
On-site delivery
A consultant-led team delivers procedures within Trust theatres or minor operations facilities.
Pathway completion
Specimens are processed through Trust pathology with agreed follow-up and reporting.
- CQC-registered provider — surgical procedures, diagnostic and screening, treatment of disease, disorder or injury.
- £10m medical indemnity cover held for all insourced activity.
- GMC-registered consultant surgeons on the specialist register for their relevant specialty.
- Agreed SOPs, consent and escalation pathways before the first list runs.
Support your skin cancer pathway this quarter.
Tell us the size of the backlog and the estate you have available at weekends. We will return a costed list structure, staffing model and mobilisation timeline.
Please do not send patient-identifiable information by email. We will agree a secure NHS channel where clinical detail is needed.